Posted On: 01/31/2016 10:11:11 PM
Post# of 72447
Thanks! I like this part:
Brilacidin-Otic has shown excellent results in labratory testing of middle ear (otitis media) infection. Cellceutix intends to develop Brilacidin-Otic, currently undergoing ototoxicity testing in preparation for a clinical trial, as a topical solution to treat acute otitis media infections that drain into the external ear canal, including acute otitis externa and those that occur through a ruptured tympanic membrane or indwelling PE tube.
Upon FDA approval Brilacidin will become a household name.
Brilacidin-Otic has shown excellent results in labratory testing of middle ear (otitis media) infection. Cellceutix intends to develop Brilacidin-Otic, currently undergoing ototoxicity testing in preparation for a clinical trial, as a topical solution to treat acute otitis media infections that drain into the external ear canal, including acute otitis externa and those that occur through a ruptured tympanic membrane or indwelling PE tube.
Upon FDA approval Brilacidin will become a household name.
(0)
(0)
***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.
